Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| KYNTRA BIO, INC. | 120,000 | reported | 04 Jun 2025 | tx 20+320,442−8,520 |
| Neumora Therapeutics, Inc. | 80,000 | reported | 27 May 2026 | tx 17+540,391−303,918 |
| BIOMARIN PHARMACEUTICAL INC | 28,010 | reported | 20 May 2025 | tx 6+28,010 |
| PAREXEL INTERNATIONAL CORP | 0 | reported | 29 Sept 2017 | tx 4+6,612−6,612 |
| AGIOS PHARMACEUTICALS, INC. | 0 | reported | 20 Jun 2025 | tx 33+181,540−17,032 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | Neumora Therapeutics, Inc. | 80,000 | 0.00 USD | deriv |
| 20 Jun 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,120 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 2,816 | 0.00 USD | deriv |
| 20 Jun 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,120 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 15,768 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | KYNTRA BIO, INC. | 120,000 | 0.00 USD | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 80,000 | 0.00 USD | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 28,571 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 27,802 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 95,586 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 28,571 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 27,802 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 95,586 | — | deriv |
| 20 May 2025 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 6,650 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 27,802 | — | deriv |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 95,586 | — | deriv |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 28,571 | — | deriv |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 27,802 | — | deriv |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 28,571 | — | deriv |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 95,586 | — | deriv |
| 20 Jun 2024 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 2,120 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 11,774 | 0.00 USD | deriv |
| 13 Jun 2024 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 3,388 | 0.00 USD | |
| 13 Jun 2024 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 3,388 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Neumora Therapeutics, Inc. | 20,100 | 0.00 USD |